Adverse effects of GLP-1 receptor agonists: difference between revisions
Diff·revision 13 → 14·21:16, 13 Nov 2024
Difference between revision 13 and revision 14 of Adverse effects of GLP-1 receptor agonists. 1 line changed; the page grew by 34 bytes.
| Revision 13 — 22:13, 26 Oct 2024 ToneTilda (talk) add the medical-disclaimer cross-link 3,137 bytes ±0 | Revision 14 — 21:16, 13 Nov 2024 StubSorterBot (talk) bot: flag bare reference 3,171 bytes +34 | ||
|---|---|---|---|
| 1 | {{Infobox concept | 1 | {{Infobox concept |
| 2 | | name = Adverse effects of GLP-1 receptor agonists | 2 | | name = Adverse effects of GLP-1 receptor agonists |
| + | 3 | | subtitle = Clinical practice | |
| 3 | | Most common = Nausea, vomiting, diarrhoea, constipation | 4 | | Most common = Nausea, vomiting, diarrhoea, constipation |
| 4 | | Timing = Concentrated during escalation | 5 | | Timing = Concentrated during escalation |